RecruitingNot ApplicableNCT06066918
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
The Effect of Preventional Drug Therapy on Pain Regulation Mechanisms Among Spinal Cord Injury Patients Who Have Yet to Develop Central Pain
Sponsor
Loewenstein Hospital
Enrollment
50 participants
Start Date
Jul 13, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Up to 3 months following traumatic or non-traumatic SCL
- Ability to give informed consent and cooperate
Exclusion Criteria6
- Pregnancy
- Neurological or other medical conditions that may interfere with sensation
- Neuropathic-like pain before recruitment (described as painful sensation of electric current, burning, numbness, tingling, pricking, or squeezing)
- Being treated with Pregabalin
- Blood creatinine levels >1.2 or creatinine clearance <60
- Sensitivity to lactose
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPregabalin 75mg
Pregabalin 75 mg twice a day
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06066918
Related Trials
Spinal Cord Stimulation and Training
NCT054725841 location
Abdominal Functional Electrical Stimulation to Improve Bowel Function in Spinal Cord Injury
NCT063457811 location
Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury
NCT062130121 location
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
NCT023239451 location
Low Oxygen Therapy to Enhance Walking Recovery After SCI.
NCT065217232 locations